ClinicalTrials.Veeva

Menu

Metastases of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients. The "SCOPE-ITSCC Metastases Study"

University of Zurich (UZH) logo

University of Zurich (UZH)

Status

Active, not recruiting

Conditions

Squamous Cell Carcinoma

Treatments

Other: SCC metastasis

Study type

Observational

Funder types

Other

Identifiers

NCT01976468
SCOPE-ITSCC metastases

Details and patient eligibility

About

The investigators hypothesize that a low number of SCC in OTR will metastasize.

Full description

In a large international multicenter prospective observational study a total number of 1000 OTR (organ transplant recipients) with a histologically proven cutaneous SCC (squamous cell carcinoma) will be included in 10 centers and followed during 2 years to establish the cumulative incidence of metastases in OTR with cutaneous SCC.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Organ-transplant recipients (OTR).
  • Histologically proven cutaneous invasive SCC at time of inclusion

Exclusion criteria

  • Lack of consent.
  • History of metastases of cutaneous SCC

Trial design

100 participants in 1 patient group

SCC metastasis
Description:
organ transplant recipients
Treatment:
Other: SCC metastasis

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems